Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 44

Trial Status

Completed6

Role Distribution

Other Roles6

Activity Timeline

Clinical Trials (6)

NCT00388193Phase 2Completed
Rituximab Combined With Chemotherapy in Burkitt's Lymphoma
Acute Lymphoblastic LeukemiaBurkitt's Lymphoma
Studychair
NCT00388895Phase 2Completed
Glivec in Ph Positive Lymphoblastic Leukemia
Acute Lymphoblastic LeukemiaCromosome Philadelphia Positive
Studychair
NCT00526175Phase 4Completed
LAL-BR/2001: Study Treatment to Low Risk ALL
Acute Lymphoblastic Leukemia
Studychair

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaBurkitt Lymphoma
Similarity Score20%

Mitchell S Cairo, MD

New York Medical College

Related
13 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaBurkitt Lymphoma
Similarity Score20%

Elias Jabbour

M.D. Anderson Cancer Center

Related
15 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaBurkitt Lymphoma
Similarity Score20%

Bastida Pilar, Dr

Hospital Universitari Materno-Infantil Vall d'Hebron

Related
1 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

PETHEMA Foundation
Collaborated on 1 trial
Similarity Score14%

Bastida Pilar, Dr

Hospital Materno-Infantil Vall d'Hebron

Related
1 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

PETHEMA Foundation
Collaborated on 1 trial
Similarity Score14%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score10%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score10%

Partow Kebriaei, MD

M.D. Anderson Cancer Center

Related
10 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score10%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score10%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT00388193Phase 2StudyChair

Rituximab Combined With Chemotherapy in Burkitt's Lymphoma

Acute Lymphoblastic LeukemiaBurkitt's Lymphoma
Completed
NCT00388895Phase 2StudyChair

Glivec in Ph Positive Lymphoblastic Leukemia

Acute Lymphoblastic LeukemiaCromosome Philadelphia Positive
Completed
NCT00494897Phase 4StudyDirector

PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia
Completed
NCT00526175Phase 4StudyChair

LAL-BR/2001: Study Treatment to Low Risk ALL

Acute Lymphoblastic Leukemia
Completed
NCT00526305Phase 4StudyChair

LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive

Acute Lymphoblastic Leukemia
Completed
NCT00526409Phase 4StudyChair

LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia
Completed

All 6 trials loaded